APA (7th ed.) Citation

Harrison, C. N., Schaap, N., Vannucchi, A. M., Kiladjian, J., Jourdan, E., Silver, R. T., . . . Mesa, R. A. (2021). Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial. Wiley.

Chicago Style (17th ed.) Citation

Harrison, Claire N., et al. Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial. Wiley, 2021.

MLA (9th ed.) Citation

Harrison, Claire N., et al. Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial. Wiley, 2021.